InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nanobiotix S.A.

NBTX Clue Score35
France Fiscal year ends December CIK 0001760854
$23.68 +3.41% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $23.68 +105.38% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Dec 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue3.5Operating income−30.1Net income−30.3EPS, diluted−1.55Fiscal year 2019Revenue2.5 −27.0%Operating income−46.8Net income−50.9EPS, diluted−2.35Fiscal year 2020Revenue2.5 −1.1%Operating income−36.4Net income−33.6EPS, diluted−1.38Fiscal year 2021Revenue2.6 +5.4%Operating income−52.6Net income−47.1EPS, diluted−1.35Fiscal year 2022Revenue4.8 +80.4%Operating income−46.7Net income−57.0EPS, diluted−1.64Fiscal year 2023Revenue36.2 +658.1%Operating income−26.8Net income−39.7EPS, diluted−1.08Fiscal year 2024Revenue−7.2 −119.9%Operating income−68.4Net income−68.1EPS, diluted−1.44Fiscal year 2025Revenue32.6Operating income−10.8Net income−24.0EPS, diluted−0.50
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 3.5 2.5 2.5 2.6 4.8 36.2 −7.2 32.6
Growth −27.0% −1.1% +5.4% +80.4% +658.1% −119.9%
Operating income −30.1 −46.8 −36.4 −52.6 −46.7 −26.8 −68.4 −10.8
Net income −30.3 −50.9 −33.6 −47.1 −57.0 −39.7 −68.1 −24.0
Growth
EPS, diluted −1.55 −2.35 −1.38 −1.35 −1.64 −1.08 −1.44 −0.50
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Operating margin−864.2%Net margin−872.2%Free cash flow margin−758.9%Fiscal year 2019Operating margin−1,841.0%Net margin−2,003.7%Free cash flow margin−1,663.1%Fiscal year 2020Operating margin−1,450.2%Net margin−1,337.2%Free cash flow margin−1,100.1%Fiscal year 2021Operating margin−1,986.4%Net margin−1,778.0%Free cash flow margin−1,137.1%Fiscal year 2022Operating margin−977.8%Net margin−1,194.3%Free cash flow margin−778.8%Fiscal year 2023Operating margin−74.0%Net margin−109.6%Free cash flow margin−35.4%Fiscal year 2024Operating margin951.1%Net margin947.5%Free cash flow margin283.6%Fiscal year 2025Operating margin−33.2%Net margin−73.5%Free cash flow margin−104.2%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −864.2% −1,841.0% −1,450.2% −1,986.4% −977.8% −74.0% 951.1% −33.2%
Net margin −872.2% −2,003.7% −1,337.2% −1,778.0% −1,194.3% −109.6% 947.5% −73.5%
Free cash flow margin −758.9% −1,663.1% −1,100.1% −1,137.1% −778.8% −35.4% 283.6% −104.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−26.0Capital expenditure−0.4Free cash flow−26.4Fiscal year 2019Operating cash flow−41.2Capital expenditure−1.1Free cash flow−42.3Fiscal year 2020Operating cash flow−27.5Capital expenditure−0.1Free cash flow−27.6Fiscal year 2021Operating cash flow−29.9Capital expenditure−0.2Free cash flow−30.1Fiscal year 2022Operating cash flow−37.1Capital expenditure−0.1Free cash flow−37.2Fiscal year 2023Operating cash flow−12.5Capital expenditure−0.3Free cash flow−12.8Fiscal year 2024Operating cash flow−19.6Capital expenditure−0.8Free cash flow−20.4Fiscal year 2025Operating cash flow−33.4Capital expenditure−0.5Free cash flow−34.0
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −26.0 −41.2 −27.5 −29.9 −37.1 −12.5 −19.6 −33.4
Capital expenditure −0.4 −1.1 −0.1 −0.2 −0.1 −0.3 −0.8 −0.5
Free cash flow −26.4 −42.3 −27.6 −30.1 −37.2 −12.8 −20.4 −34.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2018Cash36.2Shareholders’ equity14.2Fiscal year 2019Cash35.1Shareholders’ equity−1.9Fiscal year 2020Cash119.2Shareholders’ equity70.5Fiscal year 2021Cash83.9Shareholders’ equity26.8Fiscal year 2022Cash41.4Shareholders’ equity−27.0Fiscal year 2023Cash75.3Shareholders’ equity−1.8Fiscal year 2024Cash49.7Shareholders’ equity−65.7Fiscal year 2025Cash52.8Shareholders’ equity−84.5
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 36.2 35.1 119.2 83.9 41.4 75.3 49.7 52.8
Shareholders’ equity 14.2 −1.9 70.5 26.8 −27.0 −1.8 −65.7 −84.5

In millions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
3.5 2.5 2.5 2.6 4.8 36.2 −7.2 32.6
Growth −27.0% −1.1% +5.4% +80.4% +658.1% −119.9%
20.9 30.4 24.3 30.4 32.6 38.4 40.5 23.1
12.7 18.9 14.6 19.4 17.9 22.0 20.5 20.4
−30.1 −46.8 −36.4 −52.6 −46.7 −26.8 −68.4 −10.8
Growth
−30.3 −50.9 −33.6 −47.0 −57.0 −39.7 −68.1 −24.0
0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0
−30.3 −50.9 −33.6 −47.1 −57.0 −39.7 −68.1 −24.0
Growth
Per share
−1.55 −2.35 −1.38 −1.35 −1.64 −1.08 −1.44 −0.50
−1.55 −2.35 −1.38 −1.35 −1.64 −1.08 −1.44 −0.50
Growth
19,633 21,632 24,386 34,733 34,852 36,928 47,265 47,820

Shown in EUR as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 67.0% a year over five years.
  • Operating margin is up 1,417.0 points on five years ago, at -33.2%.
  • A net loss in 8 of 8 years on file.